IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 83 filers reported holding IGM BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,442,980 | +20.1% | 292,532 | +32.7% | 0.00% | – |
| Q2 2023 | $2,034,448 | -25.2% | 220,417 | +11.3% | 0.00% | – |
| Q1 2023 | $2,721,303 | +82488.9% | 198,057 | +2.2% | 0.00% | – |
| Q4 2022 | $3,295 | -99.9% | 193,750 | +5.9% | 0.00% | -100.0% |
| Q3 2022 | $4,161,000 | +17.3% | 183,015 | -7.0% | 0.00% | 0.0% |
| Q2 2022 | $3,546,000 | -38.1% | 196,710 | -8.2% | 0.00% | 0.0% |
| Q1 2022 | $5,727,000 | +34.5% | 214,282 | +47.6% | 0.00% | 0.0% |
| Q4 2021 | $4,258,000 | -57.8% | 145,181 | -5.4% | 0.00% | 0.0% |
| Q3 2021 | $10,087,000 | -16.4% | 153,399 | +5.8% | 0.00% | -50.0% |
| Q2 2021 | $12,064,000 | +15.6% | 145,009 | +6.6% | 0.00% | 0.0% |
| Q1 2021 | $10,434,000 | -0.5% | 136,066 | +14.6% | 0.00% | 0.0% |
| Q4 2020 | $10,482,000 | +18.1% | 118,726 | -1.2% | 0.00% | 0.0% |
| Q3 2020 | $8,873,000 | -24.5% | 120,218 | -25.3% | 0.00% | -33.3% |
| Q2 2020 | $11,745,000 | +38.1% | 160,903 | +6.2% | 0.00% | +50.0% |
| Q1 2020 | $8,507,000 | -9.0% | 151,519 | -38.2% | 0.00% | +100.0% |
| Q4 2019 | $9,352,000 | – | 245,108 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
| Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
| Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
| Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
| Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
| Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
| Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
| Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
| Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
| Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |